{"transactions":[{"id":740816,"issuer":{"id":5029,"kind":"organization","name":"Faeth Therapeutics, Inc.","symbol":"FTH"},"owners":[{"id":39068,"kind":"person","name":"Donenberg Phillip B.","position":1,"cik":"0001238120","reported_name":"Donenberg Phillip B.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2026-06-13T00:35:33.000Z","date":"2026-06-10","kind":"grant","planned":false,"acquired":true,"shares":12500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The shares subject to the option vest and become exercisable in 12 equal monthly installments over a one year period such that the option is fully vested on June 10, 2027, subject to the Reporting Person's continuous service with the Issuer as of each such vesting date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares subject to the option vest and become exercisable in 12 equal monthly installments over a one year period such that the option is fully vested on June 10, 2027, subject to the Reporting Person's continuous service with the Issuer as of each such vesting date."}],"balance_after":12500,"derivative":{"exercise_price":11.41,"expiration_date":"2036-06-09","underlying":"Common Stock","underlying_shares":12500},"source":{"system":"sec-edgar","filing":"0001238120-26-000011","document":"form4-06132026_120629.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1829802/000123812026000011/form4-06132026_120629.xml","form_type":"4"}},{"id":742934,"issuer":{"id":5328,"kind":"organization","name":"Tectonic Therapeutic, Inc.","symbol":"TECX"},"owners":[{"id":39068,"kind":"person","name":"Donenberg Phillip B.","position":1,"cik":"0001238120","reported_name":"Donenberg Phillip B.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2026-06-10T16:45:07.000Z","date":"2026-06-09","kind":"grant","planned":false,"acquired":true,"shares":10200,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option shall vest in full on the earliest of (i) June 9, 2027, (ii) the date of the Issuer's 2027 Annual Meeting of Stockholders, or (iii) a \"Change in Control\" (as defined in the Issuer's 2024 Equity Incentive Plan) of the Issuer, subject in each case, to the Reporting Person providing continuous service to the Issuer on each such date."}],"balance_after":10200,"derivative":{"exercise_price":28.56,"expiration_date":"2036-06-08","underlying":"Common Stock","underlying_shares":10200},"source":{"system":"sec-edgar","filing":"0001238120-26-000010","document":"form4-06102026_040603.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1238120/000123812026000010/form4-06102026_040603.xml","form_type":"4"}},{"id":756117,"issuer":{"id":4549,"kind":"organization","name":"Taysha Gene Therapies, Inc."},"owners":[{"id":39068,"kind":"person","name":"Donenberg Phillip B.","position":1,"cik":"0001238120","reported_name":"Donenberg Phillip B.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2026-06-02T20:30:18.000Z","date":"2026-06-01","kind":"grant","planned":false,"acquired":true,"shares":42671,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The shares vest on the earlier of June 1, 2027 or the next annual stockholders meeting, subject to the Reporting Person's continued service as a director through the applicable vesting date."}],"balance_after":42671,"derivative":{"exercise_price":5.97,"expiration_date":"2036-06-01","underlying":"Common Stock","underlying_shares":42671},"source":{"system":"sec-edgar","filing":"0001238120-26-000008","document":"form4-06022026_040614.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1806310/000123812026000008/form4-06022026_040614.xml","form_type":"4"}},{"id":756116,"issuer":{"id":4549,"kind":"organization","name":"Taysha Gene Therapies, Inc."},"owners":[{"id":39068,"kind":"person","name":"Donenberg Phillip B.","position":1,"cik":"0001238120","reported_name":"Donenberg Phillip B.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-06-02T20:30:18.000Z","date":"2026-06-01","kind":"grant","planned":false,"acquired":true,"shares":21335,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents a restricted stock unit (\"RSU\") award. The RSUs will vest on the earlier of June 1, 2027 or the next annual stockholders meeting, subject to the Reporting Person's continued service as a director through the applicable vesting date."}],"balance_after":241289,"source":{"system":"sec-edgar","filing":"0001238120-26-000008","document":"form4-06022026_040614.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1806310/000123812026000008/form4-06022026_040614.xml","form_type":"4"}},{"id":809252,"issuer":{"id":5029,"kind":"organization","name":"Faeth Therapeutics, Inc.","symbol":"FTH"},"owners":[{"id":39068,"kind":"person","name":"Donenberg Phillip B.","position":1,"cik":"0001238120","reported_name":"Donenberg Phillip B.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2026-04-14T21:15:54.000Z","date":"2026-04-10","kind":"grant","planned":false,"acquired":true,"shares":23100,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents a supplemental option grant to align the Reporting Person's total initial director option grant with the Company's non-employee director compensation policy, which was amended on April 10, 2026 to provide for an initial option grant of 25,000 shares to new directors. The Reporting Person previously received an initial grant of 1,900 shares in February 2026; this supplemental grant of 23,100 shares reflects the difference."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The shares subject to the option vest and become exercisable in 36 equal monthly installments over a three year period such that the option is fully vested on the third anniversary of the date of grant, or April 10, 2029, subject to the Reporting Person's continuous service with the Issuer as of each such vesting date."}],"balance_after":23100,"derivative":{"exercise_price":29.89,"expiration_date":"2036-04-09","underlying":"Common Stock","underlying_shares":23100},"source":{"system":"sec-edgar","filing":"0001238120-26-000006","document":"form4-04142026_090450.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1829802/000123812026000006/form4-04142026_090450.xml","form_type":"4"}},{"id":903498,"issuer":{"id":5029,"kind":"organization","name":"Faeth Therapeutics, Inc.","symbol":"FTH"},"owners":[{"id":39068,"kind":"person","name":"Donenberg Phillip B.","position":1,"cik":"0001238120","reported_name":"Donenberg Phillip B.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2026-02-17T22:01:24.000Z","date":"2026-02-13","kind":"grant","planned":false,"acquired":true,"shares":1900,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares subject to the option vest and become exercisable in 36 equal monthly installments over a three year period such that the option is fully vested on the third anniversary of the date of grant, or February 13, 2029, subject to the Reporting Person's continuous service with the Issuer as of each such vesting date."}],"balance_after":1900,"derivative":{"exercise_price":9.09,"expiration_date":"2036-02-12","underlying":"Common Stock","underlying_shares":1900},"source":{"system":"sec-edgar","filing":"0001238120-26-000004","document":"form4-02172026_100221.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1829802/000123812026000004/form4-02172026_100221.xml","form_type":"4"}},{"id":1114747,"issuer":{"id":5328,"kind":"organization","name":"Tectonic Therapeutic, Inc.","symbol":"TECX"},"owners":[{"id":39068,"kind":"person","name":"Donenberg Phillip B.","position":1,"cik":"0001238120","reported_name":"Donenberg Phillip B.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2025-06-11T16:30:30.000Z","date":"2025-06-09","kind":"grant","planned":false,"acquired":true,"shares":10200,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option shall vest in full on the earliest of (i) June 9, 2026, (ii) the date of the Issuer's 2026 Annual Meeting of stockholders, or (iii) a \"Change in Control\" (as defined in the Issuer's 2024 Equity Incentive Plan) of the Issuer, subject in each case, to the Reporting Person providing continuous service to the Issuer on each such date."}],"balance_after":10200,"derivative":{"exercise_price":24.48,"expiration_date":"2035-06-08","underlying":"Common Stock","underlying_shares":10200},"source":{"system":"sec-edgar","filing":"0001415889-25-016676","document":"form4-06112025_040615.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1238120/000141588925016676/form4-06112025_040615.xml","form_type":"4"}},{"id":1123809,"issuer":{"id":4549,"kind":"organization","name":"Taysha Gene Therapies, Inc."},"owners":[{"id":39068,"kind":"person","name":"Donenberg Phillip B.","position":1,"cik":"0001238120","reported_name":"Donenberg Phillip B.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2025-06-04T20:15:20.000Z","date":"2025-06-02","kind":"grant","planned":false,"acquired":true,"shares":113246,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The shares vest on the earlier of June 2, 2026 or the next annual stockholders meeting, subject to the Reporting Person's continued service as a director through the applicable vesting date."}],"balance_after":113246,"derivative":{"exercise_price":2.785,"expiration_date":"2035-06-02","underlying":"Common Stock","underlying_shares":113246},"source":{"system":"sec-edgar","filing":"0001415889-25-015573","document":"form4-06042025_040607.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1806310/000141588925015573/form4-06042025_040607.xml","form_type":"4"}},{"id":1123808,"issuer":{"id":4549,"kind":"organization","name":"Taysha Gene Therapies, Inc."},"owners":[{"id":39068,"kind":"person","name":"Donenberg Phillip B.","position":1,"cik":"0001238120","reported_name":"Donenberg Phillip B.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-06-04T20:15:20.000Z","date":"2025-06-02","kind":"grant","planned":false,"acquired":true,"shares":56623,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents a restricted stock unit (\"RSU\") award. The RSUs will vest on the earlier of June 2, 2026 or the next annual stockholders meeting, subject to the Reporting Person's continued service as a director through the applicable vesting date."}],"balance_after":219954,"source":{"system":"sec-edgar","filing":"0001415889-25-015573","document":"form4-06042025_040607.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1806310/000141588925015573/form4-06042025_040607.xml","form_type":"4"}},{"id":1470511,"issuer":{"id":5328,"kind":"organization","name":"Tectonic Therapeutic, Inc.","symbol":"TECX"},"owners":[{"id":39068,"kind":"person","name":"Donenberg Phillip B.","position":1,"cik":"0001238120","reported_name":"Donenberg Phillip B.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2024-06-24T16:37:33.000Z","date":"2024-06-20","kind":"grant","planned":false,"acquired":true,"shares":11760,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"1/3rd of the shares subject to the option will vest on June 20, 2025, and the balance will vest in equal monthly installments thereafter over the next 24 months, subject in each case to the continuous service of the Reporting Person to the Issuer through the applicable vesting date."}],"balance_after":11760,"derivative":{"exercise_price":16.8,"expiration_date":"2034-06-19","underlying":"Common Stock","underlying_shares":11760},"source":{"system":"sec-edgar","filing":"0001415889-24-017998","document":"form4-06242024_080629.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1238120/000141588924017998/form4-06242024_080629.xml","form_type":"4"}},{"id":1497239,"issuer":{"id":4549,"kind":"organization","name":"Taysha Gene Therapies, Inc."},"owners":[{"id":39068,"kind":"person","name":"Donenberg Phillip B.","position":1,"cik":"0001238120","reported_name":"Donenberg Phillip B.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2024-05-31T20:18:21.000Z","date":"2024-05-29","kind":"grant","planned":false,"acquired":true,"shares":98440,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The shares vest on the earlier of May 29, 2025 or the next annual stockholders meeting, subject to the Reporting Person's continued service as a director through the applicable vesting date."}],"balance_after":98440,"derivative":{"exercise_price":3.17,"expiration_date":"2034-05-29","underlying":"Common Stock","underlying_shares":98440},"source":{"system":"sec-edgar","filing":"0001415889-24-015039","document":"form4-05312024_040505.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1806310/000141588924015039/form4-05312024_040505.xml","form_type":"4"}},{"id":1497238,"issuer":{"id":4549,"kind":"organization","name":"Taysha Gene Therapies, Inc."},"owners":[{"id":39068,"kind":"person","name":"Donenberg Phillip B.","position":1,"cik":"0001238120","reported_name":"Donenberg Phillip B.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-05-31T20:18:21.000Z","date":"2024-05-29","kind":"grant","planned":false,"acquired":true,"shares":49220,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents a restricted stock unit (\"RSU\") award. The RSUs will vest on the earlier of May 29, 2025 or the next annual stockholders meeting, subject to the Reporting Person's continued service as a director through the applicable vesting date."}],"balance_after":163331,"source":{"system":"sec-edgar","filing":"0001415889-24-015039","document":"form4-05312024_040505.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1806310/000141588924015039/form4-05312024_040505.xml","form_type":"4"}},{"id":1806741,"issuer":{"id":4549,"kind":"organization","name":"Taysha Gene Therapies, Inc."},"owners":[{"id":39068,"kind":"person","name":"Donenberg Phillip B.","position":1,"cik":"0001238120","reported_name":"Donenberg Phillip B.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-08-17T00:51:19.000Z","date":"2023-08-16","kind":"purchase","planned":false,"acquired":true,"shares":111111,"price":0.9,"value":99999.9,"ownership":{"direct":true},"balance_after":114111,"source":{"system":"sec-edgar","filing":"0001209191-23-046148","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1806310/000120919123046148/doc4.xml","form_type":"4"}},{"id":1844705,"issuer":{"id":4549,"kind":"organization","name":"Taysha Gene Therapies, Inc."},"owners":[{"id":39068,"kind":"person","name":"Donenberg Phillip B.","position":1,"cik":"0001238120","reported_name":"Donenberg Phillip B.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2023-06-26T20:49:29.000Z","date":"2023-06-22","kind":"grant","planned":false,"acquired":true,"shares":36200,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares vest on the earlier of June 22, 2024 or the next annual stockholders meeting, subject to the Reporting Person's continued service as a director through the applicable vesting date."}],"balance_after":36200,"derivative":{"exercise_price":0.72,"expiration_date":"2033-06-22","underlying":"Common Stock","underlying_shares":36200},"source":{"system":"sec-edgar","filing":"0001209191-23-039731","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1806310/000120919123039731/doc4.xml","form_type":"4"}},{"id":1862013,"issuer":{"id":5328,"kind":"organization","name":"Tectonic Therapeutic, Inc.","symbol":"TECX"},"owners":[{"id":39068,"kind":"person","name":"Donenberg Phillip B.","position":1,"cik":"0001238120","reported_name":"Donenberg Phillip B.","relationship":{"director":true}}],"security":"Stock Option (Right to Buy)","published_at":"2023-06-08T16:30:53.000Z","date":"2023-06-06","kind":"grant","planned":false,"acquired":true,"shares":17643,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option shall vest in full upon the earlier of June 6, 2024 or the date of the Issuer's 2024 Annual Meeting of Stockholders, subject to the reporting person's continued service as a director through such vesting date."}],"balance_after":17643,"derivative":{"exercise_price":1.09,"expiration_date":"2033-06-05","underlying":"Common Stock","underlying_shares":17643},"source":{"system":"sec-edgar","filing":"0001127602-23-018290","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1238120/000112760223018290/form4.xml","form_type":"4"}},{"id":2224676,"issuer":{"id":4549,"kind":"organization","name":"Taysha Gene Therapies, Inc."},"owners":[{"id":39068,"kind":"person","name":"Donenberg Phillip B.","position":1,"cik":"0001238120","reported_name":"Donenberg Phillip B.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2022-06-22T20:40:40.000Z","date":"2022-06-17","kind":"grant","acquired":true,"shares":15500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares vest on the earlier of June 17, 2023 or the next annual stockholders meeting, subject to the Reporting Person's continued service as a director though the applicable vesting date."}],"balance_after":15500,"derivative":{"exercise_price":2.81,"expiration_date":"2032-06-17","underlying":"Common Stock","underlying_shares":15500},"source":{"system":"sec-edgar","filing":"0001209191-22-038691","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1806310/000120919122038691/doc4.xml","form_type":"4"}},{"id":2235681,"issuer":{"id":5328,"kind":"organization","name":"Tectonic Therapeutic, Inc.","symbol":"TECX"},"owners":[{"id":39068,"kind":"person","name":"Donenberg Phillip B.","position":1,"cik":"0001238120","reported_name":"Donenberg Phillip B.","relationship":{"director":true}}],"security":"Stock Option (Right to Buy)","published_at":"2022-06-10T16:43:17.000Z","date":"2022-06-08","kind":"grant","acquired":true,"shares":17478,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option shall vest in full upon the earlier of June 8, 2023 or the date of the Issuer's 2023 Annual Meeting of Stockholders, subject to the reporting person's continued service as a director through such vesting date."}],"balance_after":17478,"derivative":{"exercise_price":1.06,"expiration_date":"2032-06-07","underlying":"Common Stock","underlying_shares":17478},"source":{"system":"sec-edgar","filing":"0001127602-22-017246","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1238120/000112760222017246/form4.xml","form_type":"4"}},{"id":2235680,"issuer":{"id":5328,"kind":"organization","name":"Tectonic Therapeutic, Inc.","symbol":"TECX"},"owners":[{"id":39068,"kind":"person","name":"Donenberg Phillip B.","position":1,"cik":"0001238120","reported_name":"Donenberg Phillip B.","relationship":{"director":true}}],"security":"Stock Option (Right to Buy)","published_at":"2022-06-10T16:43:17.000Z","date":"2022-06-08","kind":"grant","acquired":true,"shares":17478,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option shall vest in full upon the earlier of June 8, 2023 or the date of the Issuer's 2023 Annual Meeting of Stockholders, subject to the reporting person's continued service as a director through such vesting date."}],"balance_after":17478,"derivative":{"exercise_price":1.06,"expiration_date":"2032-06-07","underlying":"Common Stock","underlying_shares":17478},"source":{"system":"sec-edgar","filing":"0001127602-22-017246","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1238120/000112760222017246/form4.xml","form_type":"4"}},{"id":2415233,"issuer":{"id":4549,"kind":"organization","name":"Taysha Gene Therapies, Inc."},"owners":[{"id":39068,"kind":"person","name":"Donenberg Phillip B.","position":1,"cik":"0001238120","reported_name":"Donenberg Phillip B.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-02-03T12:04:01.000Z","date":"2022-02-02","kind":"purchase","acquired":true,"shares":3000,"price":7.78,"value":23340.0,"ownership":{"direct":true},"balance_after":3000,"source":{"system":"sec-edgar","filing":"0001209191-22-006641","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1806310/000120919122006641/doc4.xml","form_type":"4"}},{"id":2662326,"issuer":{"id":4549,"kind":"organization","name":"Taysha Gene Therapies, Inc."},"owners":[{"id":39068,"kind":"person","name":"Donenberg Phillip B.","position":1,"cik":"0001238120","reported_name":"Donenberg Phillip B.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2021-06-21T21:05:39.000Z","date":"2021-06-17","kind":"grant","acquired":true,"shares":15500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares vest on the earlier of June 17, 2022 or the next annual stockholders meeting, subject to continued service as a director though the applicable vesting date."}],"balance_after":15500,"derivative":{"exercise_price":25.04,"expiration_date":"2031-06-17","underlying":"Common Stock","underlying_shares":15500},"source":{"system":"sec-edgar","filing":"0001209191-21-042112","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1806310/000120919121042112/doc4.xml","form_type":"4"}},{"id":2669905,"issuer":{"id":5328,"kind":"organization","name":"Tectonic Therapeutic, Inc.","symbol":"TECX"},"owners":[{"id":39068,"kind":"person","name":"Donenberg Phillip B.","position":1,"cik":"0001238120","reported_name":"Donenberg Phillip B.","relationship":{"director":true}}],"security":"Stock Option (Right to Buy)","published_at":"2021-06-14T17:04:09.000Z","date":"2021-06-10","kind":"grant","acquired":true,"shares":17438,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option shall vest in full upon the earlier of June 10, 2022 or the date of the Issuer's 2022 Annual Meeting of Stockholders, subject to the reporting person's continued service as a director through such vesting date."}],"balance_after":17438,"derivative":{"exercise_price":9.63,"expiration_date":"2031-06-09","underlying":"Common Stock","underlying_shares":17438},"source":{"system":"sec-edgar","filing":"0001127602-21-019804","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1238120/000112760221019804/form4.xml","form_type":"4"}},{"id":2849427,"issuer":{"id":5328,"kind":"organization","name":"Tectonic Therapeutic, Inc.","symbol":"TECX"},"owners":[{"id":39068,"kind":"person","name":"Donenberg Phillip B.","position":1,"cik":"0001238120","reported_name":"Donenberg Phillip B.","relationship":{"director":true}}],"security":"Common Stock","published_at":"2021-02-18T19:06:50.000Z","date":"2021-02-17","kind":"purchase","acquired":true,"shares":2000,"price":11.71,"value":23420.0,"ownership":{"direct":true},"balance_after":2000,"source":{"system":"sec-edgar","filing":"0001127602-21-006556","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1238120/000112760221006556/form4.xml","form_type":"4"}},{"id":3022670,"issuer":{"id":4549,"kind":"organization","name":"Taysha Gene Therapies, Inc."},"owners":[{"id":39068,"kind":"person","name":"Donenberg Phillip B.","position":1,"cik":"0001238120","reported_name":"Donenberg Phillip B.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2020-09-25T21:09:51.000Z","date":"2020-09-23","kind":"grant","acquired":true,"shares":31000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares subject to the Option vest in 36 equal monthly installments, subject to the Reporting Person continuing to provide service through each such date."}],"balance_after":31000,"derivative":{"exercise_price":20,"expiration_date":"2030-09-23","underlying":"Common Stock","underlying_shares":31000},"source":{"system":"sec-edgar","filing":"0001209191-20-052112","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1806310/000120919120052112/doc4.xml","form_type":"4"}},{"id":3120113,"issuer":{"id":5328,"kind":"organization","name":"Tectonic Therapeutic, Inc.","symbol":"TECX"},"owners":[{"id":39068,"kind":"person","name":"Donenberg Phillip B.","position":1,"cik":"0001238120","reported_name":"Donenberg Phillip B.","relationship":{"director":true}}],"security":"Stock Option (Right to Buy)","published_at":"2020-06-05T17:15:53.000Z","date":"2020-06-04","kind":"grant","acquired":true,"shares":14000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option shall vest in full upon the earlier of June 4, 2021 or the date of the Issuer's 2021 Annual Meeting of Stockholders, subject to the reporting person's continued service as a director through such vesting date."}],"balance_after":14000,"derivative":{"exercise_price":21.91,"expiration_date":"2030-06-03","underlying":"Common Stock","underlying_shares":14000},"source":{"system":"sec-edgar","filing":"0001127602-20-019024","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1238120/000112760220019024/form4.xml","form_type":"4"}},{"id":3491108,"issuer":{"id":5328,"kind":"organization","name":"Tectonic Therapeutic, Inc.","symbol":"TECX"},"owners":[{"id":39068,"kind":"person","name":"Donenberg Phillip B.","position":1,"cik":"0001238120","reported_name":"Donenberg Phillip B.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy","published_at":"2019-06-13T17:09:02.000Z","date":"2019-06-11","kind":"grant","acquired":true,"shares":9675,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option shall vest in full upon the earlier of June 11, 2020 or the date of the Issuer's 2020 Annual Meeting of Stockholders, subject to the reporting person's continued service as a director through such vesting date."}],"balance_after":9675,"derivative":{"exercise_price":13.6,"expiration_date":"2029-06-10","underlying":"Common Stock","underlying_shares":9675},"source":{"system":"sec-edgar","filing":"0000899243-19-016854","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1238120/000089924319016854/doc4.xml","form_type":"4"}},{"id":3867496,"issuer":{"id":149352,"kind":"organization","name":"Assertio Therapeutics, Inc","symbol":"ASRT"},"owners":[{"id":39068,"kind":"person","name":"Donenberg Phillip B.","position":1,"cik":"0001238120","reported_name":"Donenberg Phillip B.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP and CFO"}}],"security":"Restricted Stock Unit","published_at":"2018-07-16T20:10:12.000Z","date":"2018-07-16","kind":"grant","acquired":true,"shares":87163,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents the contingent right to receive one share of common stock upon vesting of the unit."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"These restricted stock units are scheduled to vest 33.33% on July 16, 2019, 33.33% on July 16, 2020 and 33.33% on July 16, 2021, assuming continued employment through the applicable vest period."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"These restricted stock units are scheduled to vest 33.33% on July 16, 2019, 33.33% on July 16, 2020 and 33.33% on July 16, 2021, assuming continued employment through the applicable vest period."}],"balance_after":87163,"derivative":{"underlying":"Common Stock","underlying_shares":87163},"source":{"system":"sec-edgar","filing":"0001179110-18-009699","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1005201/000117911018009699/edgar.xml","form_type":"4"}},{"id":3884824,"issuer":{"id":5328,"kind":"organization","name":"Tectonic Therapeutic, Inc.","symbol":"TECX"},"owners":[{"id":39068,"kind":"person","name":"Donenberg Phillip B.","position":1,"cik":"0001238120","reported_name":"Donenberg Phillip B.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2018-06-22T20:00:45.000Z","date":"2018-06-20","kind":"grant","acquired":true,"shares":18743,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares vest in 36 equal monthly installments following the closing of the Issuer's initial public offering."}],"balance_after":18743,"derivative":{"exercise_price":19,"expiration_date":"2028-06-20","underlying":"Common Stock","underlying_shares":18743},"source":{"system":"sec-edgar","filing":"0000899243-18-017787","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1238120/000089924318017787/doc4.xml","form_type":"4"}},{"id":3932953,"issuer":{"id":166664,"kind":"organization","name":"AveXis, Inc.","symbol":"AVXS"},"owners":[{"id":39068,"kind":"person","name":"Donenberg Phillip B.","position":1,"cik":"0001238120","reported_name":"Donenberg Phillip B.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2018-05-15T12:29:15.000Z","date":"2018-05-15","kind":"disposition_to_issuer","acquired":false,"shares":15000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"On April 6, 2018, the Issuer entered into an Agreement and Plan of Merger (the \"Merger Agreement\") with Novartis AG, a company organized under the laws of Switzerland (\"Parent\"), and Novartis AM Merger Corporation, a Delaware corporation and an indirect wholly-owned subsidiary of the Parent (\"Purchaser\"). Pursuant to the terms of the Merger Agreement and the Offer (as defined in the Merger Agreement), each share of the Issuer's common stock (the \"Common Stock\") held by the Reporting Person was acquired, subject to adjustment, at a purchase price of $218.00 per share (the \"Offer Price\") in cash."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Pursuant to the Merger Agreement, each outstanding stock option was canceled in exchange for a lump sum cash payment equal the excess of (A) the Offer Price minus (B) the Exercise Price, multiplied by the number of shares of Common Stock underlying the option."}],"balance_after":0,"derivative":{"exercise_price":133.8,"expiration_date":"2028-03-13","underlying":"Common Stock","underlying_shares":15000},"source":{"system":"sec-edgar","filing":"0001209191-18-030117","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1652923/000120919118030117/doc4.xml","form_type":"4"}},{"id":3932952,"issuer":{"id":166664,"kind":"organization","name":"AveXis, Inc.","symbol":"AVXS"},"owners":[{"id":39068,"kind":"person","name":"Donenberg Phillip B.","position":1,"cik":"0001238120","reported_name":"Donenberg Phillip B.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2018-05-15T12:29:15.000Z","date":"2018-05-15","kind":"disposition_to_issuer","acquired":false,"shares":10000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"On April 6, 2018, the Issuer entered into an Agreement and Plan of Merger (the \"Merger Agreement\") with Novartis AG, a company organized under the laws of Switzerland (\"Parent\"), and Novartis AM Merger Corporation, a Delaware corporation and an indirect wholly-owned subsidiary of the Parent (\"Purchaser\"). Pursuant to the terms of the Merger Agreement and the Offer (as defined in the Merger Agreement), each share of the Issuer's common stock (the \"Common Stock\") held by the Reporting Person was acquired, subject to adjustment, at a purchase price of $218.00 per share (the \"Offer Price\") in cash."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Pursuant to the Merger Agreement, each outstanding stock option was canceled in exchange for a lump sum cash payment equal the excess of (A) the Offer Price minus (B) the Exercise Price, multiplied by the number of shares of Common Stock underlying the option."}],"balance_after":0,"derivative":{"exercise_price":100.52,"expiration_date":"2027-10-19","underlying":"Common Stock","underlying_shares":10000},"source":{"system":"sec-edgar","filing":"0001209191-18-030117","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1652923/000120919118030117/doc4.xml","form_type":"4"}},{"id":3932951,"issuer":{"id":166664,"kind":"organization","name":"AveXis, Inc.","symbol":"AVXS"},"owners":[{"id":39068,"kind":"person","name":"Donenberg Phillip B.","position":1,"cik":"0001238120","reported_name":"Donenberg Phillip B.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2018-05-15T12:29:15.000Z","date":"2018-05-15","kind":"disposition_to_issuer","acquired":false,"shares":4406,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"On April 6, 2018, the Issuer entered into an Agreement and Plan of Merger (the \"Merger Agreement\") with Novartis AG, a company organized under the laws of Switzerland (\"Parent\"), and Novartis AM Merger Corporation, a Delaware corporation and an indirect wholly-owned subsidiary of the Parent (\"Purchaser\"). Pursuant to the terms of the Merger Agreement and the Offer (as defined in the Merger Agreement), each share of the Issuer's common stock (the \"Common Stock\") held by the Reporting Person was acquired, subject to adjustment, at a purchase price of $218.00 per share (the \"Offer Price\") in cash."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Pursuant to the Merger Agreement, each outstanding stock option was canceled in exchange for a lump sum cash payment equal the excess of (A) the Offer Price minus (B) the Exercise Price, multiplied by the number of shares of Common Stock underlying the option."}],"balance_after":0,"derivative":{"exercise_price":88.08,"expiration_date":"2027-09-15","underlying":"Common Stock","underlying_shares":4406},"source":{"system":"sec-edgar","filing":"0001209191-18-030117","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1652923/000120919118030117/doc4.xml","form_type":"4"}},{"id":3932950,"issuer":{"id":166664,"kind":"organization","name":"AveXis, Inc.","symbol":"AVXS"},"owners":[{"id":39068,"kind":"person","name":"Donenberg Phillip B.","position":1,"cik":"0001238120","reported_name":"Donenberg Phillip B.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2018-05-15T12:29:15.000Z","date":"2018-05-15","kind":"disposition_to_issuer","acquired":false,"shares":5594,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"On April 6, 2018, the Issuer entered into an Agreement and Plan of Merger (the \"Merger Agreement\") with Novartis AG, a company organized under the laws of Switzerland (\"Parent\"), and Novartis AM Merger Corporation, a Delaware corporation and an indirect wholly-owned subsidiary of the Parent (\"Purchaser\"). Pursuant to the terms of the Merger Agreement and the Offer (as defined in the Merger Agreement), each share of the Issuer's common stock (the \"Common Stock\") held by the Reporting Person was acquired, subject to adjustment, at a purchase price of $218.00 per share (the \"Offer Price\") in cash."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Pursuant to the Merger Agreement, each outstanding stock option was canceled in exchange for a lump sum cash payment equal the excess of (A) the Offer Price minus (B) the Exercise Price, multiplied by the number of shares of Common Stock underlying the option."}],"balance_after":0,"derivative":{"exercise_price":77.24,"expiration_date":"2027-05-10","underlying":"Common Stock","underlying_shares":5594},"source":{"system":"sec-edgar","filing":"0001209191-18-030117","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1652923/000120919118030117/doc4.xml","form_type":"4"}},{"id":3932949,"issuer":{"id":166664,"kind":"organization","name":"AveXis, Inc.","symbol":"AVXS"},"owners":[{"id":39068,"kind":"person","name":"Donenberg Phillip B.","position":1,"cik":"0001238120","reported_name":"Donenberg Phillip B.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2018-05-15T12:29:15.000Z","date":"2018-05-15","kind":"disposition_to_issuer","acquired":false,"shares":20000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"On April 6, 2018, the Issuer entered into an Agreement and Plan of Merger (the \"Merger Agreement\") with Novartis AG, a company organized under the laws of Switzerland (\"Parent\"), and Novartis AM Merger Corporation, a Delaware corporation and an indirect wholly-owned subsidiary of the Parent (\"Purchaser\"). Pursuant to the terms of the Merger Agreement and the Offer (as defined in the Merger Agreement), each share of the Issuer's common stock (the \"Common Stock\") held by the Reporting Person was acquired, subject to adjustment, at a purchase price of $218.00 per share (the \"Offer Price\") in cash."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Pursuant to the Merger Agreement, each outstanding stock option was canceled in exchange for a lump sum cash payment equal the excess of (A) the Offer Price minus (B) the Exercise Price, multiplied by the number of shares of Common Stock underlying the option."}],"balance_after":0,"derivative":{"exercise_price":37.58,"expiration_date":"2026-09-06","underlying":"Common Stock","underlying_shares":20000},"source":{"system":"sec-edgar","filing":"0001209191-18-030117","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1652923/000120919118030117/doc4.xml","form_type":"4"}},{"id":3932948,"issuer":{"id":166664,"kind":"organization","name":"AveXis, Inc.","symbol":"AVXS"},"owners":[{"id":39068,"kind":"person","name":"Donenberg Phillip B.","position":1,"cik":"0001238120","reported_name":"Donenberg Phillip B.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2018-05-15T12:29:15.000Z","date":"2018-05-15","kind":"disposition_to_issuer","acquired":true,"shares":3800,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"On April 6, 2018, the Issuer entered into an Agreement and Plan of Merger (the \"Merger Agreement\") with Novartis AG, a company organized under the laws of Switzerland (\"Parent\"), and Novartis AM Merger Corporation, a Delaware corporation and an indirect wholly-owned subsidiary of the Parent (\"Purchaser\"). Pursuant to the terms of the Merger Agreement and the Offer (as defined in the Merger Agreement), each share of the Issuer's common stock (the \"Common Stock\") held by the Reporting Person was acquired, subject to adjustment, at a purchase price of $218.00 per share (the \"Offer Price\") in cash."},{"field":"shares","element":"transactionShares","label":"F2","text":"Represents 3,800 shares underlying Restricted Stock Units (the \"RSUs\"). Pursuant to the Merger Agreement, each outstanding RSU was canceled in exchange for a lump sum cash payment equal to (i) the Offer Price multiplied by (ii) the number of shares of Common Stock underlying the RSU."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"On April 6, 2018, the Issuer entered into an Agreement and Plan of Merger (the \"Merger Agreement\") with Novartis AG, a company organized under the laws of Switzerland (\"Parent\"), and Novartis AM Merger Corporation, a Delaware corporation and an indirect wholly-owned subsidiary of the Parent (\"Purchaser\"). Pursuant to the terms of the Merger Agreement and the Offer (as defined in the Merger Agreement), each share of the Issuer's common stock (the \"Common Stock\") held by the Reporting Person was acquired, subject to adjustment, at a purchase price of $218.00 per share (the \"Offer Price\") in cash."}],"balance_after":3800,"source":{"system":"sec-edgar","filing":"0001209191-18-030117","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1652923/000120919118030117/doc4.xml","form_type":"4"}},{"id":3981969,"issuer":{"id":166664,"kind":"organization","name":"AveXis, Inc.","symbol":"AVXS"},"owners":[{"id":39068,"kind":"person","name":"Donenberg Phillip B.","position":1,"cik":"0001238120","reported_name":"Donenberg Phillip B.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2018-03-27T17:27:31.000Z","date":"2018-03-13","kind":"grant","acquired":true,"shares":15000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The option shall vest and become exercisable as to 25% of the shares underlying the option on March 13, 2019; the remaining shares shall vest in 36 equal monthly installments beginning on April 13, 2019, subject to the Reporting Person providing continuous service to the Issuer on each such date."}],"balance_after":15000,"derivative":{"exercise_price":133.8,"expiration_date":"2028-03-13","underlying":"Common Stock","underlying_shares":15000},"source":{"system":"sec-edgar","filing":"0001209191-18-021777","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1652923/000120919118021777/doc4.xml","form_type":"4"}},{"id":3981968,"issuer":{"id":166664,"kind":"organization","name":"AveXis, Inc.","symbol":"AVXS"},"owners":[{"id":39068,"kind":"person","name":"Donenberg Phillip B.","position":1,"cik":"0001238120","reported_name":"Donenberg Phillip B.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2018-03-27T17:27:31.000Z","date":"2018-03-13","kind":"grant","acquired":true,"shares":3800,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"These shares are represented by restricted stock units. Each restricted stock unit represents a contingent right to receive one share of common stock of the Issuer. The shares underlying this restricted stock award will vest in 3 equal annual installments beginning on March 13, 2019, such that the restricted stock award will be fully vested on March 13, 2021, subject to the Reporting Person's continuous service with the Issuer on each such date."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"These shares are represented by restricted stock units. Each restricted stock unit represents a contingent right to receive one share of common stock of the Issuer. The shares underlying this restricted stock award will vest in 3 equal annual installments beginning on March 13, 2019, such that the restricted stock award will be fully vested on March 13, 2021, subject to the Reporting Person's continuous service with the Issuer on each such date."}],"balance_after":3800,"source":{"system":"sec-edgar","filing":"0001209191-18-021777","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1652923/000120919118021777/doc4.xml","form_type":"4"}},{"id":4182462,"issuer":{"id":166664,"kind":"organization","name":"AveXis, Inc.","symbol":"AVXS"},"owners":[{"id":39068,"kind":"person","name":"Donenberg Phillip B.","position":1,"cik":"0001238120","reported_name":"Donenberg Phillip B.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2017-10-20T17:04:56.000Z","date":"2017-10-19","kind":"grant","acquired":true,"shares":10000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option shall vest and become exercisable as to 25% of the shares underlying the option on October 19, 2018; the remaining shares shall vest in 36 equal monthly installments beginning on November 19, 2018, subject to the Reporting Person providing continuous service to the Issuer on each such date."}],"balance_after":10000,"derivative":{"exercise_price":100.52,"expiration_date":"2027-10-18","underlying":"Common Stock","underlying_shares":10000},"source":{"system":"sec-edgar","filing":"0001209191-17-057658","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1652923/000120919117057658/doc4.xml","form_type":"4"}}]}